Vaso Corp

Earnings Score
Moat Score

Market Cap $22.79M
PE -193
Debt $8.00K
Cash $26.84M
EV -$4.04M
FCF $NaN

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$118.00K
EBIT	$101.00K
ROE	-0%
ROA	0%
Equity	$25.66M
Growth Stability	-11K%
PE	-193.15
PEG	-13.71
PB	0.89
P/S	0.28
Price/Cash	1.18
Debt/Equity	0
Net Margins	-2%
Gross Margins	60%
Op. Margins	0%
Earnings CAGR	-0%
Sales Growth YoY	7%
Sales Growth QoQ	3%
Sales CAGR	2%
FCF CAGR	3%
Equity CAGR	10%
Earnings Stability	0
Earnings Growth YoY	-199%
Earnings Growth QoQ	-202%

Earnings CAGR 5Y	14%
Sales CAGR 5Y	3%
FCF CAGR 5Y	3%
Equity CAGR 5Y	60%
Earnings CAGR 3Y	2%
Sales CAGR 3Y	2%
Equity CAGR 3Y	43%
Market Cap	$22.79M
Revenue	$81.65M
Assets	$73.94M
Total Debt	$8.00K
Cash	$26.84M
Shares Outstanding	175.32M
EV	-4.04M
Earnings Score	6%
Moat Score	16%
Working Capital	12.82M
Current Ratio	1.43
Gross Profit	$48.88M
Shares Growth 3y	1%
Equity Growth QoQ	-4%
Equity Growth YoY	0%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Vaso Corporation is a medical technology company. It provides diverse product and service categories, including noninvasive monitoring and therapeutic devices, diagnostic imaging equipment, and information technology for enterprises and clinical customers. The company currently operates in three distinct business units namely IT; Professional sales and Equipment. It generates maximum revenue from the IT segment. IT segment primarily focuses on healthcare IT and managed network technology services.

SEC Filings

Direct access to Vaso Corp (VASO) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Vaso Corp compare to its competitors?

Not enough data to generate a comparison chart between Vaso Corp and its competitors. Please check back later.

Peter Lynch's Chart

This chart shows the current pricing of Vaso Corp compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR -0%

Stability 0%

loading chart...

Vaso Corp Discounted Cash Flow

Fully customizable DCF calculator online for Vaso Corp.

Years

Calculation mode

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
DCF		$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Value	$0

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Net Margins	3%	7%	1%	-6%	-5%	0%	1%	-8%	-15%	6%	-2%
ROA	-	8%	3%	-7%	-7%	2%	2%	12%	10%	6%	0%
ROE	-	33%	6%	-50%	-67%	1%	7%	-54%	-52%	18%	-0%

Bad Net Margins (-2.01%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	1.59	4.13	-16.22	-5.01	-4.76	2.38	0	0	-	-
Debt over Equity	0.3	0.76	1.07	1.37	3.61	2.09	2.31	0	0	0	0
Growth Stability	-	-	-	-236%	-11K%	-	-	-	-	-	-11K%

Neutral Debt/FCF ratio (-)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Good Debt/Equity ratio (0)

The company is not overleveraged and has a good balance between equity and debt.

Bad Graham’s Stability (-11K%)

The company has a bad stability in its earnings, which is a sign of a bad competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	63%	27%	0%	2%	2%	-8%	8%	6%	1%	3%
Earnings YoY growth	-	239%	-79%	-654%	-18%	-101%	818%	-2K%	95%	-140%	14%
Equity YoY growth	-	51%	10%	-29%	-39%	3%	-12%	122%	102%	17%	60%
FCF YoY growth	-	155%	-40%	-123%	421%	-37%	-294%	50%	87%	-	3%